|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||201.31 g/mol g·mol−1|
|3D model (JSmol)|
EXP-561 is an investigational drug that acts as an inhibitor of the reuptake of serotonin, dopamine, and norepinephrine. It was developed in the 1960s by Du Pont and was suggested as a potential antidepressant but failed in trials and was never marketed.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|